Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·
How researchers will follow sleep and memory over two years
Clinical TrialA registered Alzheimer's study pairs 24-hour sleep recordings with repeated memory tests to track change over two years, not test a treatment benefit.
-
Evidence date ·
What creatine might reveal about inflammation in cerebral palsy
Review or Meta-AnalysisA 2022 opinion paper proposes testing creatine in cerebral palsy models, separating inflammation in muscle and other tissues from inflammation in the brain.
-
Evidence date ·
How researchers are investigating shared facial features in creatine transporter deficiency
Clinical TrialA registry-described study examines photographs of males with creatine transporter deficiency to investigate shared facial features and future diagnostic usefulness.
-
Evidence date ·
What a fisetin-versus-placebo trial can reveal about immune-linked lung disease
Clinical TrialA phase 2 registry record compares brief fisetin and placebo cycles, measuring immune cells alongside lung health, walking, quality of life and harms.
-
Evidence date ·
Can a six-week day-care program help with sleep problems and distress when dementia starts early?
Clinical TrialA planned study pairs needs assessment with six weekly day-care sessions for sleep problems and distress in young-onset dementia. Benefits remain unproven.
-
Evidence date ·
Why compare two forms of brain stimulation for sleep problems in Alzheimer’s disease
Clinical TrialA registry outlines a trial of two forms of electrical brain stimulation for sleep problems in Alzheimer's disease; it reports no treatment results.
-
Evidence date ·
Why researchers are comparing heart images with neurological assessments
Clinical TrialA registry study pairs radioactive-tracer heart imaging with neurological assessments across sleep, movement and memory changes; its diagnostic value remains to be tested.
-
Evidence date ·
Removing persistent senescent cells or quieting their harmful signals
Review or Meta-AnalysisA 2022 review compares drugs that remove senescent cells with those that quiet their signals, from human tissue findings to platelet toxicity.
-
Evidence date ·
Could targeting cells that stopped dividing preserve health with age?
Review or Meta-AnalysisA 2022 review compares drugs that quiet senescent-cell signals with drugs that kill them, and explains what early patient findings measured.










